inVentiv Health Consulting MD Neel Patel, presenting results of the firm's annual survey of industry dealmakers' intentions at a session on June 9 – the final day of BIO – shared data on the varying levels of buyer demand versus asset availability from sellers. Antibiotics emerged as the area with the greatest demand surplus, with pain, CNS and gastrointestinal indications also evident as strong markets for sellers, while supply now looks to be outstripping demand in oncology, hepatic indications and dermatology.
Overall, 2016 looks like a seller's market, particularly for firms with later-stage assets to partner, license or sell. However, total...








